Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Alibaba | 4.04% | $40.81M | $333.05B | 7.44% | 68 Neutral | |
| TSMC | 3.80% | $38.39M | $1.57T | 86.91% | 81 Outperform | |
| Novartis | 3.79% | $38.31M | $312.45B | 48.76% | 80 Outperform | |
| AstraZeneca | 3.26% | $32.93M | $323.92B | 30.42% | 80 Outperform | |
| Sumitomo Mitsui | 3.25% | $32.86M | $145.77B | 52.91% | 76 Outperform | |
| Bank Of Montreal | 3.08% | $31.13M | C$138.34B | 45.33% | 74 Outperform | |
| Mitsubishi UFJ | 2.99% | $30.27M | $212.77B | 53.16% | 77 Outperform | |
| Grupo Cibest | 2.87% | $28.97M | $20.11B | 85.93% | 71 Outperform | |
| Agnico Eagle | 2.72% | $27.47M | $110.59B | 137.52% | 80 Outperform | |
| Barclays | 2.72% | $27.46M | $90.09B | 71.21% | 77 Outperform |